Venture Capital · San Francisco (United States) · Founded 2007
The Column Group (TCG) is a venture ecosystem dedicated to fueling scientific innovation in the life sciences industry. They deploy an edge-to-edge investment model, supporting companies from inception through exit. TCG has a two-decade history of nurturing science into successful ventures and therapeutic breakthroughs.
Series A, Series B
BioTech, Pharma
Judo Bio, Carmot, Peloton Therapeutics, Aragon, Seragon, Neurona, Constellation, Exonics, Flexus Biosciences, ORIC Pharmaceuticals, Tenaya Therapeutics, Remix Therapeutics, NGM Bio, Velia, A2 Biotherapeutics, Accent Therapeutics, Nura Bio, Plexium, Synthekine, InduPro, RAPT Therapeutics, Kallyope, Cajal Neuroscience, Hexagon Bio, Tr1X Bio, Lyterian, Arcus Biosciences, Kimia Therapeutics, Casma Therapeutics, Escient Pharmaceuticals, Circle Pharma, Eikon Therapeutics, Gritstone, Immune Design, Nurix, Kenai, Revolution Medicines, Atavistik Bio